Business Description
Milestone Pharmaceuticals Inc
NAICS : 325412
SIC : 3741
ISIN : CA59935V1076
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.28 | |||||
Equity-to-Asset | 0.22 | |||||
Debt-to-Equity | 3.09 | |||||
Debt-to-EBITDA | -0.9 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -6.58 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 8.3 | |||||
3-Year EPS without NRI Growth Rate | 6.5 | |||||
3-Year FCF Growth Rate | 14.4 | |||||
3-Year Book Growth Rate | -52.9 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.41 | |||||
9-Day RSI | 53.08 | |||||
14-Day RSI | 51.8 | |||||
6-1 Month Momentum % | -43.2 | |||||
12-1 Month Momentum % | -57.4 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 10.11 | |||||
Quick Ratio | 10.11 | |||||
Cash Ratio | 9.13 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.9 | |||||
Shareholder Yield % | -54.29 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -6109.8 | |||||
Net Margin % | -5968.5 | |||||
FCF Margin % | -4653.6 | |||||
ROE % | -144.89 | |||||
ROA % | -67.07 | |||||
ROIC % | -1189.74 | |||||
ROC (Joel Greenblatt) % | -2294.26 | |||||
ROCE % | -70.62 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 74.13 | |||||
PB Ratio | 3.4 | |||||
Price-to-Tangible-Book | 3.4 | |||||
EV-to-EBIT | -1.32 | |||||
EV-to-EBITDA | -1.32 | |||||
EV-to-Forward-EBITDA | -1.4 | |||||
EV-to-Revenue | 76.02 | |||||
EV-to-Forward-Revenue | 21.78 | |||||
EV-to-FCF | -1.64 | |||||
Price-to-Net-Current-Asset-Value | 3.86 | |||||
Price-to-Net-Cash | 7.39 | |||||
Earnings Yield (Greenblatt) % | -75.76 | |||||
FCF Yield % | -51.41 |